NCT00674882

Brief Summary

This protocol allows for ongoing data collection to assess the long-term clinical and psychosocial outcomes of pediatric patients who have received a hematopoietic stem cell transplant at St. Jude Children's Research Hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
637

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 8, 2008

Completed
11.5 years until next milestone

Study Start

First participant enrolled

November 7, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 12, 2020

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 3, 2022

Completed
Last Updated

December 18, 2024

Status Verified

December 1, 2024

Enrollment Period

4 months

First QC Date

May 6, 2008

Last Update Submit

December 17, 2024

Conditions

Hematopoietic Stem Cell Transplantation

Keywords

Hematopoietic stem cell transplantFollow-up studiesOutcomes researchData collection

Outcome Measures

Primary Outcomes (1)

  • To provide ongoing review of long-term clinical and psychosocial outcomes and late effects of hematopoietic stem cell recipients at St. Jude Children's Research Hospital

    Long Term Follow Up

Study Arms (1)

Participants

Data Collection

Other: Data Collection

Interventions

Data CollectionOTHER

Data Collection, Outcomes Research, Statistical Data Analysis, Longitudinal Study

Participants

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

St. Jude patient at least one year post receipt of an autologous or allogeneic transplant for a malignant or non-malignant condition

You may qualify if:

  • St. Jude patients actively monitored in the BMT-AFU clinic after receiving HSC transplant for a malignant or non-malignant condition.
  • St. Jude alumnus who has received a hematopoietic stem cell transplant for a malignant or non-malignant condition and is monitored by the Tumor Registry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States

Location

Related Links

MeSH Terms

Interventions

Data Collection

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Brandon Triplett, MD

    St. Jude Children's Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2008

First Posted

May 8, 2008

Study Start

November 7, 2019

Primary Completion

March 12, 2020

Study Completion

October 3, 2022

Last Updated

December 18, 2024

Record last verified: 2024-12

Locations

US(1)